Zhengjiang Qian, Associate Investigator, Master's Supervisor, Shenzhen Back-up Talent. Zhengjiang Qian obtained his Ph.D. from the University of Chinese Academy of Sciences in 2014.
His main research interests focus on the molecular mechanisms, early diagnosis, and drug development of neurodegenerative diseases.
1. Qian, Z., et al., Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease. Mol Psychiatry, 2024. 29(10): p. 3040-3055.
2. Qian, Z., Y. Li, and K. Ye, Advancements and challenges in mouse models of Alzheimer's disease. Trends Mol Med, 2024. 30(12): p. 1152-1164.
3. Qian, Z., et al., Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice. Neuropsychopharmacology, 2024. 49(3): p. 620-630.
4. Qian, Z., et al., Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain. Sci Adv, 2021. 7(43): p. eabi5811.
He has published more than 20 SCI papers in total. He has directed and participated in key programs and major programs of the National Natural Science Foundation of China. He has supervised 1 PhD graduate and 3 Master's graduates through joint training programs.